{"id":"W2921353678","doi":"10.1136/ejhpharm-2019-eahpconf.269","title":"4CPS-120 Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Internal medicine; Epidermal growth factor receptor; Oncology; Lung cancer; Chemotherapy; Taxane; Erlotinib Hydrochloride; Adverse effect; Cancer; Breast cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002788546,0.0002792147,0.0005138242,0.0001773294,0.0001465633,0.00005091207,0.0001386211,0.0001314009,0.001843556],"category_scores_gemma":[0.00004717434,0.0002435564,0.000202727,0.000475232,0.00003618236,0.0004555511,0.00005293433,0.0006335304,0.0001583315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002675132,"about_ca_system_score_gemma":0.000348595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004120447,"about_ca_topic_score_gemma":0.000682927,"domain_scores_codex":[0.9976998,0.0001473169,0.0008718575,0.0006155992,0.0002740781,0.0003913643],"domain_scores_gemma":[0.9984412,0.0003989588,0.0003895369,0.0002448043,0.0002607735,0.0002647936],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003360832,0.0006065827,0.9859198,0.0006930245,0.0002709917,0.000005952942,0.0016713,0.0002087354,0.005227427,0.000004830262,0.000256299,0.004799022],"study_design_scores_gemma":[0.02112175,0.0003791597,0.9316035,0.0008339559,0.0006449881,0.00001134251,0.001699432,0.01729182,0.01074062,0.00003395948,0.01504033,0.0005991358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895211,0.0002807151,0.00005820342,0.002047624,0.002669938,0.001614059,0.00006625272,0.0001437766,0.003598335],"genre_scores_gemma":[0.9931111,0.0003739614,0.0007857602,0.002366865,0.001064948,0.000223416,0.0001584076,0.00005948894,0.001856083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05431624,"threshold_uncertainty_score":0.9990689,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03810566551067331,"score_gpt":0.4265117572884367,"score_spread":0.3884060917777634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}